-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Kiromic Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2024.
- Kiromic Biopharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$6.6M, a 18.9% decline year-over-year.
- Kiromic Biopharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$23.4M, a 8.56% decline year-over-year.
- Kiromic Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$19.9M, a 35.9% increase from 2022.
- Kiromic Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$31.1M, a 20.9% decline from 2021.
- Kiromic Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$25.7M, a 34.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)